Hui Liu

发表

Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy

Hongyu Wu, Ya-ping Xu, Fangjuan Li, 2021, Radiation oncology.

Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis

J. Hung, I. Chong, Chih-Jen Yang, 2022, Journal of clinical medicine.

Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer

Qinghua Xu, Q. Lin, Ya-ping Xu, 2020, Translational lung cancer research.

Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study

Qinghua Xu, Q. Lin, Ya-ping Xu, 2020, Annals of translational medicine.

Adjuvant chemotherapy following combined induction chemotherapy and concurrent chemoradiotherapy improves survival in N2–3-positive nasopharyngeal carcinoma patients

Yawei Yuan, Hui Liu, Kunpeng Du, 2021, Journal of Cancer Research and Clinical Oncology.

Case Report: Dual Inhibition of HDAC and BTK for Diffuse Large B-Cell Lymphoma After Failure to CD19-Targeted CAR-T Therapy

Weiguo Zhu, Hui Liu, Xiang-Qui Yuan, 2022, Frontiers in Immunology.

First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients.

James X. Sun, F. Meric-Bernstam, D. Fabrizio, 2017, JCI insight.

Successful treatment after toxic epidermal necrolysis induced by AZD-9291 in a patient with non-small cell lung cancer: A case report

Huimin Zhang, Hui Liu, Wen Li, 2021, World journal of clinical cases.

First-line continual EGFR-TKI plus local ablative therapy demonstrated survival benefit in EGFR-mutant NSCLC patients with oligoprogressive disease

Qinghua Xu, T. Jiang, S. Ren, 2019, Journal of Cancer.

Prognostic Value of NRAS Gene for Survival of Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

Xin-lin Chen, Zhengkun Hou, Qiu-Gu Huang, 2018, Asian Pacific journal of cancer prevention : APJCP.

New advances in immunotherapy for non-small cell lung cancer.

H. Qin, Hongjun Gao, F. Wang, 2018, American journal of translational research.

Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First‐Line EGFR‐TKIs

Qinghua Xu, T. Jiang, Caicun Zhou, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical observation of whole brain radiotherapy concomitant with targeted therapy for brain metastasis in non-small cell lung cancer patients with chemotherapy failure.

Jiying Wang, Yong Cai, Hui Liu, 2013, Asian Pacific journal of cancer prevention : APJCP.

Lung squamous cell carcinoma in pulmonary alveolar proteinosis.

Qinghua Xu, Wen-xin He, Yongsheng Wang, 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy

Ziyang Zhou, Xiao Song, Yong Cai, 2017, Scientific Reports.

Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial.

Hui Guo, He-gen Li, Jianhui Tian, 2014, Journal of integrative medicine.

The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis

Ya-Wei Yuan, Wen-Ze Qiu, Fang Zhang, 2021, Frontiers in Immunology.

Efficacy of ginseng and its ingredients as adjuvants to chemotherapy in non-small cell lung cancer.

Ming Kong, Fang Long, Song-Lin Li, 2021, Food & function.

First-inhuman trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients

James X. Sun, F. Meric-Bernstam, D. Fabrizio, 2018 .

Treatment and prognostic analysis of patients with leptomeningeal metastases from non-small cell lung cancer

Qinghua Xu, Caicun Zhou, S. Meng, 2015, Thoracic cancer.

Outcomes of icotinib combined with concurrent chemoradiotherapy in locally advanced cervical cancer.

Yanmei Liu, S. Ying, Wei-jun Chen, 2021, Neoplasma.

Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy

Ziyang Zhou, Hongyu Wu, Xiao Song, 2017, Scientific Reports.

Effect of induction chemotherapy on the quality-of-life in patients with advanced stage tongue cancer by a prospective study

Tao Huang, Hui Liu, Yanxia Zhao, 2018, The Journal of international medical research.

[Analysis of prognostic factors in NSCLC patients with brain metastases  diagnosed by constrast-enhanced MRI after whole brain radiotherapy].

Xiao-dong He, Hongyu Wu, Zhao-ying Sheng, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Serum CEA level change and its significance before and after Gefitinib therapy on patients with advanced non-small cell lung cancer.

L. Qu, H. Qin, Hongjun Gao, 2013, Asian Pacific journal of cancer prevention : APJCP.

Aggressive local therapy for de novo metastatic breast cancer: Challenges and updates (Review)

Bailong Liu, Min Liu, Hui Liu, 2023, Oncology reports.